347 related articles for article (PubMed ID: 30320382)
1. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y
Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382
[TBL] [Abstract][Full Text] [Related]
2. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
3. Significance of nuclear LOXL2 inhibition in fibroblasts and myofibroblasts in the fibrotic process of acute respiratory distress syndrome.
Matsuo A; Tanida R; Yanagi S; Tsubouchi H; Miura A; Shigekusa T; Matsumoto N; Nakazato M
Eur J Pharmacol; 2021 Feb; 892():173754. PubMed ID: 33248114
[TBL] [Abstract][Full Text] [Related]
4. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
5. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
[TBL] [Abstract][Full Text] [Related]
6. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of MEN1 gene in radiation-induced pulmonary fibrosis in mice.
Wei W; Zhang HY; Gong XK; Dong Z; Chen ZY; Wang R; Yi JX; Shen YN; Jin SZ
Gene; 2018 Dec; 678():252-260. PubMed ID: 30099020
[TBL] [Abstract][Full Text] [Related]
10. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
11. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
[TBL] [Abstract][Full Text] [Related]
13. BACH1 transcriptionally upregulates FOSL2 to induce M2 macrophages phenotype by activating TGFβ/SMAD signaling to promote the transformation of lung fibroblasts into myofibroblasts.
Liu Y; Li X; Yang Y
Tissue Cell; 2024 Jun; 88():102407. PubMed ID: 38776730
[TBL] [Abstract][Full Text] [Related]
14. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
Ba YD; Sun JH; Zhao XX
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
[TBL] [Abstract][Full Text] [Related]
16. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.
Aschner Y; Khalifah AP; Briones N; Yamashita C; Dolgonos L; Young SK; Campbell MN; Riches DW; Redente EF; Janssen WJ; Henson PM; Sap J; Vacaresse N; Kapus A; McCulloch CA; Zemans RL; Downey GP
Am J Pathol; 2014 May; 184(5):1489-502. PubMed ID: 24650563
[TBL] [Abstract][Full Text] [Related]
18. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway.
Li S; Xu A; Li Y; Tan C; La Regina G; Silvestri R; Wang H; Qi W
Eur J Pharmacol; 2021 Jul; 903():174135. PubMed ID: 33940030
[TBL] [Abstract][Full Text] [Related]
19. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.
Hsu YA; Chang CY; Lan JL; Li JP; Lin HJ; Chen CS; Wan L; Liu FT
J Biomed Sci; 2020 Jan; 27(1):24. PubMed ID: 31937306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
